General
Lupin Neurosciences is committed to working with Healthcare Professionals to develop science-based solutions that stretch beyond access to lifechanging treatment options to optimize patient care in underserved neurological diseases.
WMS: 28th International Annual Congress of the World Muscle Society, Charleston, USA 3 – 7 October 2023
Myotonic Dystrophy
P387
Initiation and follow-up of mexiletine treatment in adult myotonic dystrophy patients: an expert opinion
Wahbi K, Bassez G, Duchateau J, Salort-Campana E, Vicart S, Labombarda F, Sellal JM, Deharo JC, Zozulya-Weidenfeller A.
WMS Cardimex Abstract
WMS Cardimex Poster
P389
RevEal the burdeN on daily life for myotonic dyStrophy patients due to myotoniA: preliminary results of the ENSA survey
Sansone V, Ashley EJ , Montagnese F, Gagnon C, Nowak U, Dang U, Turner C, Nikolenko N, Tard C, Zozulya-Weidenfeller A.
WMS ENSA Abstract
WMS ENSA Poster